✦ LIBER ✦

350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor

✍ Scribed by Snidow, Jerry; Miller, Hugh; Valenzuela, Guillermo; Thornton, Steve; Stier, Brendt; Clayton, Linda; Fossler, Mike; Montague, Tim; Beach, Kathleen; Williams, Pauline

Book ID: 119185468
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 123 KB
Volume: 208
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2012.10.515

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind placebo-controlled trial

A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (antocin) in the treatment of preterm labor

✍ B.M. Sibai; R. Romero; L. Sanchez-Ramos; G. Valenzuela; J.C. Veille; B. Tabor; J 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB

An oxytocin receptor antagonist (atosiba

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue

✍ Roberto Romero; Baha M. Sibai; Luis Sanchez-Ramos; Guillermo J. Valenzuela; Jean 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A double-blind placebo-controlled trial

A double-blind placebo-controlled trial of oxytocin receptor antagonist (Antocin) maintenance therapy in patients with preterm labor

✍ L. Sanchez-Ramos; G. Valenzuela; R. Romero; H. Silver; W. Koltun; L. Millar; J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The effect of barusiban, a selective oxy

The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial

✍ Steven Thornton; Thomas M. Goodwin; Gorm Greisen; Morten Hedegaard; Joan-Carles 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Vaginal progesterone reduces the rate of

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial

✍ S. S. Hassan; R. Romero; D. Vidyadhari; S. Fusey; J. K. Baxter; M. Khandelwal; J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Silodosin, a new α1A-adrenoceptor-select

Silodosin, a new α1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men

✍ Kazuki Kawabe; Masaki Yoshida; Yukio Homma; for the Silodosin Clinical Study Gro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB